Why is Soni Medicare falling/rising?

As of 10-Jul, Soni Medicare Ltd is currently priced at 55.82, reflecting a decline of 1.13, or 1.98%. The stock has been underperforming, having lost 3.94% over the last two days and showing a performance today that is 0.98% lower than its sector. Despite a strong year-to-date return of 71.02% and an impressive 116.95% return over the past year, the stock's recent movement is negatively impacted by falling investor participation, with delivery volume dropping by 57.03% against the five-day average. Additionally, while the company has an attractive valuation with a return on capital employed (ROCE) of 7.7 and is trading at a discount compared to peers, it faces challenges due to high debt levels and reported losses, which contribute to a weak long-term fundamental strength.
In the broader market context, Soni Medicare's short-term performance contrasts with the benchmark, as it has outperformed the Sensex over the past week with a return of 3.39% compared to a slight decline of 0.06% for the index. However, the stock's recent decline suggests that despite its strong historical performance, current market conditions and internal financial challenges are weighing on investor sentiment. The high debt-to-equity ratio and low ability to service debt further complicate the outlook, indicating that while the stock has shown remarkable growth in the past, its immediate future may be more uncertain.